Mantle Cell Lymphoma Treatment Market Share, Size, Analysis & Forecast with Upcoming Trends 2017-2025

Mantle Cell Lymphoma Treatment Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025

The latest market report published by Credence Research, Inc. “Mantle Cell Lymphoma Treatment Market - Growth, Future Prospects, Competitive Analysis, 2017 - 2025,” the global mantle cell lymphoma treatment market is set to grow at a CAGR of 4.8 % from 2017 to 2025.

Browse the full report Mantle Cell Lymphoma Treatment Market - Growth, Future Prospects, Competitive Analysis, 2017 – 2025 at

Market Insights

It is very important in patients suffering with lymphoma cancer to identify the subtype during diagnosis, as the treatment usually depends on that particular subtype. Common biomarkers of mantle cell lymphoma are overexpression of cyclin D1 proteins, reciprocal translocation observed in chromosomes 11 and 14 and CD20 antigen as a surface marker on the B cells. As majority of the patients undergoing aggressive chemotherapy have shown disease relapse the USFDA has designed the treatment regimen for the durable treatment of mantle cell lymphoma. R-CHOP is a combination therapy consisting of rituximab in combination with doxorubicin, cyclophosphamide, prednisone and vincristine is preferred with autologous stem cell transplant to resist disease relapse. VcR-CHOP comprising of bortezomib, cyclophosphamide, rituxan, doxorubicin, vincristine and prednisone is prescribed for patients previously not treated for mantle cell lymphoma.

Click Here To Browse Report on Mantle Cell Lymphoma Treatment Market:

Rituximab is considered as the first line of treatment by USFDA either as a monotherapy or in combination with other chemotherapy drugs; its ability to bind to CD20 antigen present on the cell surface of B cells and destroys the tumor cells by apoptosis. This makes rituximab the most efficient drug in the treatment of mantle cell lymphoma. Increasing cases of relapsed mantle cell lymphoma and its drug compatibility with the chemotherapy drugs used as adjuvants in the dosage regimen contributes towards the significant market growth of ibrutinib. It is noteworthy to notice that in 2020 generic competition will be faced by lenalidomide and bortezomib.

Rising prevalence of mantle cell lymphoma and the domicile of pharmaceutical companies with promising product pipeline has resulted in the dominance of North America in the global mantel cell lymphoma treatment market. Asia Pacific highlights an attractive market destination for the treatment of mantle cell lymphoma due to developing healthcare infrastructure, rampant growth in multispecialty clinic diagnosing, and treating mantle cell lymphoma.

The mantle cell lymphoma treatment market includes major players such as F.Hoffman La Roche Ltd., Abbvie, Inc., Astellas Pharma, Inc., Biogen, Inc., Bayer AG, Bristol-Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, GlaxoSmithKline Plc, Amgen, Inc., Gilead Sciences, Inc. and Johnson and Johnson.

Key Market Movements:

Technological advancement in the diagnostic procedures has identified more number of mantle cell lymphoma cases in non-Hodgkin’s lymphoma patients.
Increasing research and development activities in the healthcare sector has resulted in a promising product pipeline
Regulatory agencies providing supportive environment to expedite the drug approval for treatment of mantle cell lymphoma
Latest Reports:

Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market:

Opioid Induced Constipation (OIC) Drugs Market:

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared for this task.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
Ph: 1-800-361-8290

Contact Details

Company Name: Credence Research
Issued By: Johnson Paul
Phone: 18003618290
Address: 105 N 1st ST #429, SAN JOSE, CA 95103, United States
State: United States
Zip: 95103
Country: United States
Website: Visit the website

Keywords : Mantle Cell Lymphoma Treatment Market,

by Johnson Paul (few months ago!)

Latest Press Releases

Global E-textbook Rental Market by Product Type, by Manufacturing Process: Global Market Size..

Ready for high speed: OM5 on board of the tde plug-and-play platforms

Smart Agriculture Solution Market Global Industry Insights till 2025

6th International Conference & Exhibition on Advanced & Nano Materials to be held in Quebec C..

Virtualized Radio Access Network (vRAN) Market by Manufacturers, Countries, Type and Applicat..

Compact Fluorescent Tube Market Research Report 2018

NES Global Talent reveals 2018 Middle Eastern energy trends

Buy Online Fildena 25mg

Commodity Research Report Ways2Capital 19 March 2018

Antiperspirants: A Cause of Member odor?

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.